BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thorpy MJ, Dauvilliers Y. Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Medicine 2015;16:9-18. [DOI: 10.1016/j.sleep.2014.10.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Ingram DG, Jesteadt L, Crisp C, Simon SL. Perceived challenges in pediatric narcolepsy: a survey of parents, youth, and sleep physicians. J Clin Sleep Med 2021;17:13-22. [PMID: 32895119 DOI: 10.5664/jcsm.8774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Mori T, Uzawa N, Iwase Y, Masukawa D, Rahmadi M, Hirayama S, Hokazono M, Higashiyama K, Shioda S, Suzuki T. Narcolepsy-like sleep disturbance in orexin knockout mice are normalized by the 5-HT1A receptor agonist 8-OH-DPAT. Psychopharmacology 2016;233:2343-53. [DOI: 10.1007/s00213-016-4282-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
3 Iranzo A, Serralheiro P, Schuller JC, Schlit AF, Bentz JWG. Evaluation of the Effectiveness of the Risk Minimization Measures of Sodium Oxybate in the European Union. Drugs Real World Outcomes 2020;7:307-15. [PMID: 32989679 DOI: 10.1007/s40801-020-00212-9] [Reference Citation Analysis]
4 Lecendreux M, Plazzi G, Franco P, Jacqz-aigrain E, Robert P, Duvauchelle T, Schwartz J. Pharmacokinetics of pitolisant in children and adolescents with narcolepsy. Sleep Medicine 2020;66:220-6. [DOI: 10.1016/j.sleep.2019.10.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Dauvilliers Y, Barateau L, Lopez R, Rassu AL, Chenini S, Beziat S, Jaussent I. Narcolepsy Severity Scale: a reliable tool assessing symptom severity and consequences. Sleep 2020;43:zsaa009. [DOI: 10.1093/sleep/zsaa009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
6 Panossian LA, Avidan AY. Sleep Disorders in Neurologic Practice: A Case-based Approach. Neurol Clin 2016;34:565-94. [PMID: 27445242 DOI: 10.1016/j.ncl.2016.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Wang YQ, Liu WY, Li L, Qu WM, Huang ZL. Neural circuitry underlying REM sleep: A review of the literature and current concepts. Prog Neurobiol 2021;204:102106. [PMID: 34144122 DOI: 10.1016/j.pneurobio.2021.102106] [Reference Citation Analysis]
8 Wozniak DR, Quinnell TG. Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep 2015;7:51-61. [PMID: 26045680 DOI: 10.2147/NSS.S56077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
9 Setnik B, McDonnell M, Mills C, Scart-Grès C, Robert P, Dayno JM, Schwartz JC. Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy. Sleep 2020;43:zsz252. [PMID: 31626696 DOI: 10.1093/sleep/zsz252] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
10 DeLaney K, Buchberger A, Li L. Identification, Quantitation, and Imaging of the Crustacean Peptidome. Methods Mol Biol 2018;1719:247-69. [PMID: 29476517 DOI: 10.1007/978-1-4939-7537-2_17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
11 Thorpy MJ, Ohayon MM, Carls G, Black J, Pasta DJ, Hyman DL, Villa KF. Assessing the impact of sodium oxybate treatment on functioning, productivity, and health-related quality of life in patients with narcolepsy: findings from the Nexus Narcolepsy Registry (waves 1-4). Sleep Med 2021;84:380-8. [PMID: 34247126 DOI: 10.1016/j.sleep.2021.06.010] [Reference Citation Analysis]
12 Bosco A, Lopez R, Barateau L, Chenini S, Pesenti C, Pépin J, Jaussent I, Dauvilliers Y. Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy. Neurology 2018;90:e479-91. [DOI: 10.1212/wnl.0000000000004911] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
13 Zomorodi K, Kankam M, Lu Y. A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food. Clinical Therapeutics 2019;41:196-204. [DOI: 10.1016/j.clinthera.2018.12.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
14 Bogan RK, Feldman N, Emsellem HA, Rosenberg R, Lu Y, Bream G, Khayrallah M, Lankford DA. Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy. Sleep Med 2015;16:1102-8. [PMID: 26298786 DOI: 10.1016/j.sleep.2015.05.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
15 Trimmel K, Żebrowska M, Böck M, Stefanic A, Mayer D, Klösch G, Auff E, Seidel S. Wanted: a better cut-off value for the Epworth Sleepiness Scale. Wien Klin Wochenschr 2018;130:349-55. [PMID: 29340766 DOI: 10.1007/s00508-017-1308-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Black J, Swick T, Bogan R, Lai C, Carter LP. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy. Sleep Medicine 2016;24:57-62. [DOI: 10.1016/j.sleep.2016.07.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lai JB, Han MM, Xu Y, Hu SH. Effective treatment of narcolepsy-like symptoms with high-frequency repetitive transcranial magnetic stimulation: A case report. Medicine (Baltimore) 2017;96:e8645. [PMID: 29145290 DOI: 10.1097/MD.0000000000008645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
18 Donelson NC, Sanyal S. Use of Drosophila in the investigation of sleep disorders. Exp Neurol 2015;274:72-9. [PMID: 26160555 DOI: 10.1016/j.expneurol.2015.06.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
19 Nirogi R, Bhyrapuneni G, Muddana NR, Manoharan A, Shinde AK, Mohammed AR, Padala NP, Ajjala DR, Subramanian R, Palacharla VRC. Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy. European Journal of Pharmaceutical Sciences 2020;152:105425. [DOI: 10.1016/j.ejps.2020.105425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ruoff C, Bogan RK, Emsellem H, Feldman N, Lankford A, Bream G, Khayrallah M, Lu Y, Carter LP, Black J. Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes. Sleep Med 2017;35:12-6. [PMID: 28619176 DOI: 10.1016/j.sleep.2017.03.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
21 Kaushik MK, Aritake K, Imanishi A, Kanbayashi T, Ichikawa T, Shimizu T, Urade Y, Yanagisawa M. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Proc Natl Acad Sci U S A 2018;115:6046-51. [PMID: 29784823 DOI: 10.1073/pnas.1722686115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
22 Lamb YN. Pitolisant: A Review in Narcolepsy with or without Cataplexy. CNS Drugs 2020;34:207-18. [PMID: 31997137 DOI: 10.1007/s40263-020-00703-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
23 Calvo-Ferrandiz E, Peraita-Adrados R. Narcolepsy with cataplexy and pregnancy: a case-control study. J Sleep Res 2018;27:268-72. [PMID: 28568319 DOI: 10.1111/jsr.12567] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Hu S, Singh M, Wong J, Auckley D, Hershner S, Kakkar R, Thorpy MJ, Chung F. Anesthetic Management of Narcolepsy Patients During Surgery: A Systematic Review. Anesth Analg 2018;126:233-46. [PMID: 29257771 DOI: 10.1213/ANE.0000000000002228] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
25 Hershner S, Dauvilliers Y, Chung F, Singh M, Wong J, Gali B, Kakkar R, Mignot E, Thorpy M, Auckley D. Knowledge Gaps in the Perioperative Management of Adults With Narcolepsy: A Call for Further Research. Anesth Analg 2019;129:204-11. [PMID: 30882519 DOI: 10.1213/ANE.0000000000004088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ouyang H, Han F, Zheng Q, Zhang J. Chinese version of narcolepsy severity scale: a validation study. BMC Neurol 2019;19:334. [PMID: 31864300 DOI: 10.1186/s12883-019-1570-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
27 Calik MW. Update on the treatment of narcolepsy: clinical efficacy of pitolisant. Nat Sci Sleep 2017;9:127-33. [PMID: 28490912 DOI: 10.2147/NSS.S103462] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 6.2] [Reference Citation Analysis]
28 Lopez R, Barateau L, Evangelista E, Dauvilliers Y. Depression and Hypersomnia: A Complex Association. Sleep Med Clin 2017;12:395-405. [PMID: 28778237 DOI: 10.1016/j.jsmc.2017.03.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
29 Thorpy MJ, Shapiro C, Mayer G, Corser BC, Emsellem H, Plazzi G, Chen D, Carter LP, Wang H, Lu Y, Black J, Dauvilliers Y. A randomized study of solriamfetol for excessive sleepiness in narcolepsy. Ann Neurol 2019;85:359-70. [PMID: 30694576 DOI: 10.1002/ana.25423] [Cited by in Crossref: 69] [Cited by in F6Publishing: 44] [Article Influence: 34.5] [Reference Citation Analysis]
30 Bhattarai J, Sumerall S. Current and Future Treatment Options for Narcolepsy: A Review. Sleep Sci 2017;10:19-27. [PMID: 28966734 DOI: 10.5935/1984-0063.20170004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
31 Fujimoto T, Rikimaru K, Fukuda K, Sugimoto H, Masuda K, Ohyabu N, Banno Y, Tokunaga N, Kawamoto T, Tomata Y, Kumagai Y, Iida M, Nagano Y, Yoneyama-Hirozane M, Shimizu Y, Sasa K, Ishikawa T, Yukitake H, Ito M, Aoyama K, Matsumoto T. Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist. ACS Med Chem Lett 2022;13:457-62. [PMID: 35295087 DOI: 10.1021/acsmedchemlett.1c00626] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 de Biase S, Pellitteri G, Gigli GL, Valente M. Evaluating pitolisant as a narcolepsy treatment option. Expert Opin Pharmacother 2021;22:155-62. [PMID: 32941089 DOI: 10.1080/14656566.2020.1817387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
33 Fernandes GB, Cremaschi RC, Mangueira CLP, Tufik S, Coelho FM. Cataplexy plus presence of HLA-DQB1*0602 allele can predict Hypocretin-1 deficiency. Sleep Med 2018;45:146-7. [PMID: 29523463 DOI: 10.1016/j.sleep.2017.09.013] [Reference Citation Analysis]
34 Benmedjahed K, Wang YG, Lambert J, Evans C, Hwang S, Black J, Johns MW. Assessing sleepiness and cataplexy in children and adolescents with narcolepsy: a review of current patient-reported measures. Sleep Medicine 2017;32:143-9. [DOI: 10.1016/j.sleep.2016.12.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
35 Carter LP, Henningfield JE, Wang YG, Lu Y, Kelsh D, Vince B, Sellers E. A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor. J Psychopharmacol 2018;32:1351-61. [PMID: 30269642 DOI: 10.1177/0269881118796814] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
36 Thorpy MJ. Update on Therapy for Narcolepsy. Curr Treat Options Neurol 2015;17. [DOI: 10.1007/s11940-015-0347-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
37 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2022;39:221-43. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
38 Dauvilliers Y, Beziat S, Pesenti C, Lopez R, Barateau L, Carlander B, Luca G, Tafti M, Morin CM, Billiard M, Jaussent I. Measurement of narcolepsy symptoms: The Narcolepsy Severity Scale. Neurology 2017;88:1358-65. [PMID: 28258080 DOI: 10.1212/WNL.0000000000003787] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
39 de Biase S, Nilo A, Gigli GL, Valente M. Investigational therapies for the treatment of narcolepsy. Expert Opin Investig Drugs 2017;26:953-63. [PMID: 28726523 DOI: 10.1080/13543784.2017.1356819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Babiker MO, Prasad M. Narcolepsy in children: a diagnostic and management approach. Pediatr Neurol 2015;52:557-65. [PMID: 25838042 DOI: 10.1016/j.pediatrneurol.2015.02.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
41 Vodovar D, Duchêne A, Wimberley C, Leroy C, Pottier G, Dauvilliers Y, Giaume C, Lin JS, Mouthon F, Tournier N, Charvériat M. Cortico-Amygdala-Striatal Activation by Modafinil/Flecainide Combination. Int J Neuropsychopharmacol 2018;21:687-96. [PMID: 29635319 DOI: 10.1093/ijnp/pyy027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
42 Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y. Once-Nightly Sodium Oxybate (FT218) Demonstrated Improvement of Symptoms in a Phase 3 Randomized Clinical Trial in Patients With Narcolepsy. Sleep 2021:zsab200. [PMID: 34358324 DOI: 10.1093/sleep/zsab200] [Reference Citation Analysis]
43 Thorpy M, Morse AM. Reducing the Clinical and Socioeconomic Burden of Narcolepsy by Earlier Diagnosis and Effective Treatment. Sleep Medicine Clinics 2017;12:61-71. [DOI: 10.1016/j.jsmc.2016.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
44 Landolt HP, Holst SC, Valomon A. Clinical and Experimental Human Sleep-Wake Pharmacogenetics. Handb Exp Pharmacol 2019;253:207-41. [PMID: 30443785 DOI: 10.1007/164_2018_175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Emsellem HA, Thorpy MJ, Lammers GJ, Shapiro CM, Mayer G, Plazzi G, Chen D, Carter LP, Villa KF, Lee L, Menno D, Black J, Dauvilliers Y. Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy. Sleep Medicine 2020;67:128-36. [DOI: 10.1016/j.sleep.2019.11.1250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
46 Dauvilliers Y, Roth T, Guinta D, Alvarez-Horine S, Dynin E, Black J. Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy. Sleep Med 2017;40:53-7. [PMID: 29221779 DOI: 10.1016/j.sleep.2017.07.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
47 Thakrar C, Patel K, D'ancona G, Kent BD, Nesbitt A, Selsick H, Steier J, Rosenzweig I, Williams AJ, Leschziner GD, Drakatos P. Effectiveness and side-effect profile of stimulant therapy as monotherapy and in combination in the central hypersomnias in clinical practice. J Sleep Res 2018;27:e12627. [PMID: 29047171 DOI: 10.1111/jsr.12627] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
48 Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns. Nat Sci Sleep 2020;12:453-66. [PMID: 32765142 DOI: 10.2147/NSS.S162762] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Abad VC, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep 2017;9:39-57. [PMID: 28424564 DOI: 10.2147/NSS.S103467] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 9.4] [Reference Citation Analysis]
50 Pizza F, Jaussent I, Lopez R, Pesenti C, Plazzi G, Drouot X, Leu-Semenescu S, Beziat S, Arnulf I, Dauvilliers Y. Car Crashes and Central Disorders of Hypersomnolence: A French Study. PLoS One 2015;10:e0129386. [PMID: 26052938 DOI: 10.1371/journal.pone.0129386] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
51 de Biase S, Gigli GL, Valente M. Important decisions in choosing the pharmacotherapy for narcoleptics. Expert Opin Pharmacother 2019;20:483-6. [PMID: 30592648 DOI: 10.1080/14656566.2018.1561861] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
52 Ruda-Kucerova J, Pistovcakova J, Amchova P, Sulcova A, Machalova A. Prenatal exposure to modafinil alters behavioural response to methamphetamine in adult male mice. Int J Dev Neurosci 2018;67:37-45. [PMID: 29571720 DOI: 10.1016/j.ijdevneu.2018.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
53 Rosenthal L, Thorpy MJ, Nevsimalova S, Mayer G, Han F, Dauvilliers Y. 2018 worldwide survey of health-care providers caring for patients with narcolepsy: WSS narcolepsy task force. Sleep Med 2021;82:23-8. [PMID: 33873103 DOI: 10.1016/j.sleep.2021.03.014] [Reference Citation Analysis]
54 Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. French consensus. Management of patients with hypersomnia: Which strategy? Revue Neurologique 2017;173:8-18. [DOI: 10.1016/j.neurol.2016.09.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
55 Chaiard J, Weaver TE. Update on Research and Practices in Major Sleep Disorders: Part II-Insomnia, Willis-Ekbom Disease (Restless Leg Syndrome), and Narcolepsy. J Nurs Scholarsh 2019;51:624-33. [PMID: 31524329 DOI: 10.1111/jnu.12515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
56 Ruoff C, Swick TJ, Doekel R, Emsellem HA, Feldman NT, Rosenberg R, Bream G, Khayrallah MA, Lu Y, Black J. Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study. Sleep 2016;39:1379-87. [PMID: 27166238 DOI: 10.5665/sleep.5968] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
57 Duchêne A, Perier M, Zhao Y, Liu X, Thomasson J, Chauveau F, Piérard C, Lagarde D, Picoli C, Jeanson T, Mouthon F, Dauvilliers Y, Giaume C, Lin JS, Charvériat M. Impact of Astroglial Connexins on Modafinil Pharmacological Properties. Sleep 2016;39:1283-92. [PMID: 27091533 DOI: 10.5665/sleep.5854] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
58 Baladi MG, Forster MJ, Gatch MB, Mailman RB, Hyman DL, Carter LP, Janowsky A. Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor. J Pharmacol Exp Ther 2018;366:367-76. [PMID: 29891587 DOI: 10.1124/jpet.118.248120] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 11.8] [Reference Citation Analysis]
59 Rapanelli M, Pittenger C. Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions. Neuropharmacology 2016;106:85-90. [PMID: 26282120 DOI: 10.1016/j.neuropharm.2015.08.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
60 Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med 2020;68:97-109. [PMID: 32032921 DOI: 10.1016/j.sleep.2019.09.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
61 Barros F, Aguilar ACR, Tufik S, Coelho FM. Oral L-Carnitine used to treat narcoleptic type 1 patient during pregnancy - A case report. Sleep Sci 2018;11:215-6. [PMID: 30746038 DOI: 10.5935/1984-0063.20180035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
62 Pérez-carbonell L. Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy. Curr Treat Options Neurol 2019;21. [DOI: 10.1007/s11940-019-0595-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Carls G, Reddy SR, Broder MS, Tieu R, Villa KF, Profant J, Halbower AC. Burden of disease in pediatric narcolepsy: a claims-based analysis of health care utilization, costs, and comorbidities. Sleep Medicine 2020;66:110-8. [DOI: 10.1016/j.sleep.2019.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
64 Escalona Belmonte JJ, Romero Molina S, Sepúlveda Haro E, Malo Manso A, Guerrero Orriach JL. Narcolepsy and opioid-free anesthesia: a review and case report. Rev Esp Anestesiol Reanim (Engl Ed) 2021;68:165-70. [PMID: 33160690 DOI: 10.1016/j.redar.2020.07.002] [Reference Citation Analysis]
65 Dauvilliers Y, Arnulf I, Szakacs Z, Leu-Semenescu S, Lecomte I, Scart-Gres C, Lecomte JM, Schwartz JC; HARMONY III study group. Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study. Sleep 2019;42:zsz174. [PMID: 31529094 DOI: 10.1093/sleep/zsz174] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
66 Parmar A, Murray BJ, Narang I. Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy. Curr Neurol Neurosci Rep 2020;20:38. [PMID: 32651734 DOI: 10.1007/s11910-020-01057-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Reichert CF, Deboer T, Landolt HP. Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives. J Sleep Res 2022. [PMID: 35575450 DOI: 10.1111/jsr.13597] [Reference Citation Analysis]
68 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
69 Holst SC, Werth E, Landolt HP. [Pharmacotherapy of Sleep-Wake Disorders]. Praxis (Bern 1994) 2019;108:131-8. [PMID: 30722734 DOI: 10.1024/1661-8157/a003189] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Akpa B, Lee K. Update on Novel Medications to Treat Narcolepsy. Curr Sleep Medicine Rep 2020;6:189-97. [DOI: 10.1007/s40675-020-00178-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Giannoccaro MP, Liguori R, Plazzi G, Pizza F. Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder. Nat Sci Sleep 2021;13:557-77. [PMID: 34007229 DOI: 10.2147/NSS.S275931] [Reference Citation Analysis]
72 Barateau L, Lopez R, Dauvilliers Y. Management of Narcolepsy. Curr Treat Options Neurol 2016;18. [DOI: 10.1007/s11940-016-0429-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
73 Herbrink M, Nuijten M, Nuijen B, Huitema ADR, Beijnen JH, Hendriks VM, Blanken P, Janmohamed A, van den Brink W. Pharmacokinetics of Sustained-Release Oral Dexamphetamine Sulfate in Cocaine and Heroin-Dependent Patients. J Clin Psychopharmacol 2018;38:212-7. [PMID: 29620701 DOI: 10.1097/JCP.0000000000000862] [Reference Citation Analysis]
74 Barateau L, Lopez R, Dauvilliers Y. Treatment Options for Narcolepsy. CNS Drugs 2016;30:369-79. [PMID: 27155860 DOI: 10.1007/s40263-016-0337-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 11.6] [Reference Citation Analysis]